London Daily

Focus on the big picture.
Tuesday, Sep 16, 2025

MS charities decry UK postcode lottery for ‘life-changing’ drug

MS charities decry UK postcode lottery for ‘life-changing’ drug

Nearly 70,000 estimated to be missing out on drug available on NHS in Wales and Scotland
People with multiple sclerosis are paying up to £600 a month for a “life-changing” drug that is available on the NHS in Wales and Scotland but not in England.

Charities estimate that tens of thousands of people with MS are missing out on fampridine, which can improve a person’s ability to walk and reduce the risk of falling over.

They say the “postcode lottery” within Britain around access to the drug is “grossly unfair” to patients in England, who are being forced to live with MS’s very debilitating symptoms – which can include problems with vision, arm and leg movement, sensation and balance.

The senior Labour MP Dame Margaret Hodge has written to the health secretary, Sajid Javid, urging him to ensure that the medication is available to anyone who needs it.

Her intervention came after her constituent Steven Brooks’s ability to walk improved markedly after receiving fampridine as part of a clinical trial but whose health then declined when the trial ended and his hospital could not provide it.

“It is grossly unfair that people with MS are being denied access to fampridine – a potentially life-changing treatment – based purely on where they live in the UK,” said Phillip Anderson, the head of policy at the MS Society.

“MS is relentless, painful and disabling, but we know this treatment can make a significant difference to many people’s symptoms, including helping them to walk and manage MS fatigue.”

The disparity in access has arisen because the National Institute for Health and Care Excellence (Nice), which advises the government and NHS in England, believes fampridine does not represent value for money whereas its equivalent bodies in Wales and Scotland have recommended it.

The MS Society estimates that about 40,000 MS patients in England who would benefit from taking the drug cannot get it because of Nice’s ruling. About 200 people there have obtained it on the NHS and only after submitting an “individual funding request” – an appeal against being denied an expensive form of treatment – and showing they have exceptional need for it.

But the society says they represent only 0.5% of those who may enjoy a boost to their walking ability and quality of life if they could get fampridine on the NHS.

Biogen, which makes the medication, says an even larger number of people in England – about 65,000 – could improve their health if they could obtain the drug, and another 3,000 in Northern Ireland.

The MS Trust said patients were paying between £200 and £600 a month for the drug privately.

David Martin, the trust’s chief executive, said: “In England people with MS are being forced to make difficult choices on whether to pay for a medication that they could get for free in other parts of the UK. We at the MS Trust don’t think this is fair.

“We know that fampridine can make a difference to some people with MS who experience walking difficulties and the MS Trust would like to see fair access to this treatment across the UK.”

In her letter, Hodge asked Javid why NHS England had not been able to secure a discount on the cost of the drug from Biogen after the Scottish NHS agreed a deal to ensure its availability.

“It is not acceptable to find NHS England lagging behind and failing to offer access to fampridine for free. This failure has created a postcode lottery for MS sufferers that has severely impacted on the life of my constituent.”

Nice is updating its guidance on treating MS, which charities and patients hope will lead to the drug becoming free on the NHS in England. That is expected in 2022.

The Department of Health and Social Care said it sympathised with patients denied the drug but backed Nice’s judgment.

“We want all patients to have access to first-rate, innovative medicines and sympathise with those dealing with challenging conditions like multiple sclerosis,” a spokesperson said.

“Nice is world-renowned for its expertise in identifying effective treatments at a price that is fair to the NHS and taxpayers. They found there is currently not enough evidence on the effectiveness of this medicine compared to other effective treatments to recommend it for patients.

“We want to reassure people that Nice keeps its guidance under review. It’s currently reviewing its recommendations on fampridine and expects to publish updated guidelines next year.”
Newsletter

Related Articles

0:00
0:00
Close
U.S. and Britain Poised to Finalize Over $10 Billion in High-Tech, Nuclear and Defense Deals During Trump State Visit
China Finds Nvidia Violated Antitrust Laws in Mellanox Deal, Deepens Trade Tensions with US
US Air Force Begins Modifications on Qatar-Donated Jet Amid Plans to Use It as Air Force One
Pope Leo Warns of Societal Crisis Over Mega-CEO Pay, Citing Tesla’s Proposed Trillion-Dollar Package
Poland Green-Lights NATO Deployment in Response to Major Russian Drone Incursion
Elon Musk Retakes Lead as World’s Richest After Brief Ellison Surge
U.S. and China Agree on Framework to Shift TikTok to American Ownership
London Daily Podcast: London Massive Pro Democracy Rally, Musk Support, UK Economic Data and Premier League Results Mark Eventful Weekend
This Week in AI: Meta’s Superintelligence Push, xAI’s Ten Billion-Dollar Raise, Genesis AI’s Robotics Ambitions, Microsoft Restructuring, Amazon’s Million-Robot Milestone, and Google’s AlphaGenome Update
Le Pen Tightens the Pressure on Macron as France Edges Toward Political Breakdown
Musk calls for new UK government at huge pro-democracy rally in London, but Britons have been brainwashed to obey instead of fighting for their human rights
Elon Musk responds to post calling for the murder of Erika Kirk, widow of Charlie Kirk: 'Either we fight back or they will kill us'
Czech Republic signs €1.34 billion contract for Leopard 2A8 main battle tanks with delivery from 2028
USA: Office Depot Employees Refused to Print Poster in Memory of Charlie Kirk – and Were Fired
Proposed U.S. Bill Would Allow Civil Suits Against Judges Who Release Repeat Violent Offenders
Penske Media Sues Google Over “AI Overviews,” Claiming It Uses Journalism Without Consent and Destroys Traffic
Indian Student Engineers Propose “Project REBIRTH” to Protect Aircraft from Crashes Using AI, Airbags and Smart Materials
French Debt Downgrade Piles Pressure on Macron’s New Prime Minister
US and UK Near Tech, Nuclear and Whisky Deals Ahead of Trump Trip
One in Three Europeans Now Uses TikTok, According to the Chinese Tech Giant
Could AI Nursing Robots Help Healthcare Staffing Shortages?
NATO Deploys ‘Eastern Sentry’ After Russian Drones Violate Polish Airspace
Anesthesiologist Left Operation Mid-Surgery to Have Sex with Nurse
Tens of Thousands of Young Chinese Get Up Every Morning and Go to Work Where They Do Nothing
The New Life of Novak Djokovic
The German Owner of Politico Mathias Döpfner Eyes Further U.S. Media Expansion After Axel Springer Restructuring
Suspect Arrested: Utah Man in Custody for Charlie Kirk’s Fatal Shooting
In a politically motivated trial: Bolsonaro Sentenced to 27 Years for Plotting Coup After 2022 Defeat
German police raid AfD lawmaker’s offices in inquiry over Chinese payments
Turkish authorities seize leading broadcaster amid fraud and tax investigation
Volkswagen launches aggressive strategy to fend off Chinese challenge in Europe’s EV market
ChatGPT CEO signals policy to alert authorities over suicidal youth after teen’s death
The British legal mafia hit back: Banksy mural of judge beating protester is scrubbed from London court
Surpassing Musk: Larry Ellison becomes the richest man in the world
Embarrassment for Starmer: He fired the ambassador photographed on Epstein’s 'pedophile island'
Manhunt after 'skilled sniper' shot Charlie Kirk. Footage: Suspect running on rooftop during panic
Effective Protest Results: Nepal’s Prime Minister Resigns as Youth-Led Unrest Shakes the Nation
Qatari prime minister says Netanyahu ‘killed any hope’ for Israeli hostages
King Charles and Prince Harry Share First In-Person Moment in 19 Months
Starmer Establishes Economic ‘Budget Board’ to Centralise Policy and Rebuild Business Trust
France Erupts in Mass ‘Block Everything’ Protests on New PM’s First Day
Poland Shoots Down Russian Drones in Airspace Violation During Ukraine Attack
Brazilian police say ex-President Bolsonaro had planned to flee to Argentina seeking asylum
Trinidad Leader Applauds U.S. Naval Strike and Advocates Forceful Action Against Traffickers
Kim Jong Un Oversees Final Test of New High-Thrust Solid-Fuel Rocket Engine
Apple Introduces Ultra-Thin iPhone Air, Enhanced 17 Series and New Health-Focused Wearables
Macron Appoints Sébastien Lecornu as Prime Minister Amid Budget Crisis and Political Turmoil
Supreme Court temporarily allows Trump to pause billions in foreign aid
Charlie Sheen says his father, Martin Sheen, turned him in to the police: 'The greatest betrayal possible'
Vatican hosts first Catholic LGBTQ pilgrimage
×